Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Carbamoylaspartate)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST003104 AN005083 Metabolomics studies on human cardiac samples Heart Human Heart disease University of Sydney abundance
ST001447 AN002418 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Colon ICMS Intestine Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001453 AN002428 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Liver ICMS Liver Human Graft versus host disease University of Kentucky abundance & normalized peak area
ST001470 AN002446 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Lung ICMS Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST001472 AN002448 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Small Intestines ICMS SI Mouse Graft versus host disease University of Kentucky abundance & normalized peak area
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University AU
ST002373 AN003868 Extracellular metabolome of activated CD8+ T cells Cultured cells Mouse Johns Hopkins University AUC
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University Average Peak Area
ST001788 AN002900 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University ion counts
ST003454 AN005675 Branched chain alpha-ketoacids impact pulmonary artery smooth muscle cell metabolism Cultured cells Human Hypertension Peking University ion intensity
ST003455 AN005676 Metabolic alterations in pulmonary artery smooth muscle cells of idiopathic pulmonary arterial hypertension (IPAH) patients. Cultured cells Human Hypertension Peking University ion intensity
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University log2 fold change vs untreated
ST001324 AN002202 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*min
ST001324 AN002203 Metabolomics Adaptation of Juvenile Pacific Abalone Haliotis discus hannai to Heat Stress Pacific Abalone Institute of Oceanology, Chinese Academy of Sciences mV*s
ST003027 AN004963 NMR- and MS-based omics reveal characteristic metabolome atlas and optimize biofluid earlydiagnostic biomarkers for esophageal squamous cell carcinoma (part-Ⅳ) Tissue Human Cancer Radiology Department, Second Affiliated Hospital, Shantou University Medical College, Shantou m/z
ST001474 AN004409 Metabolomics of lung injury after allogeneic hematopoietic cell transplantation - Spleen ICMS Multiple tissues Mouse Graft versus host disease University of Kentucky natural abundance corrected and dry residue normalized peak area
ST002529 AN004163 In vivo 15N2-glutamine tracing by jugular vein infusion in PDAC-tumor bearing Lyz2-Arg1 and control mice Blood Mouse Cancer University of Chicago Natural abundance corrected percentages
ST002529 AN004163 In vivo 15N2-glutamine tracing by jugular vein infusion in PDAC-tumor bearing Lyz2-Arg1 and control mice Tumor cells Mouse Cancer University of Chicago Natural abundance corrected percentages
ST002377 AN003874 Hepatic Phosphatidylcholine Catabolism Driven by PNPLA7 and PNPLA8 Supplies Endogenous Choline to Replenish the Methionine Cycle with Methyl Groups (Pnpla7-knockout) Liver Mouse Tokyo Metropolitan Institute of Medical Science nmol
ST000570 AN000877 Metabolome analysis of the cecal contents of GF mice and GF mice colonized with dominant gut microbes present in the ceca of neonatal and adult mice Feces Mouse Keio University nmol/g
ST002170 AN003556 Cecal metabolome of specific-pathogen-free mice fed with five distinct rodent diets with varying fiber content and source. Cecum Mouse Luxembourg Institute of Health nmol/g
ST002172 AN003560 Cecal metabolome of gnotobiotic (containing a 14-member synthetic human gut microbiota), and germ-free mice fed with two distinct rodent diets with varying fiber content. Cecum Mouse Luxembourg Institute of Health nmol/g
ST002476 AN004078 High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Mouse) Intestine Mouse COVID-19 Keio University nmol/g
ST002476 AN004078 High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Mouse) Intestine Mouse Influenza Keio University nmol/g
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Fungi Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST002969 AN004878 Polar metabolites in cecal tissue of mice treated with or without ampicillin and tributyrin Cecum Mouse Bacterial infection The Rockefeller University Normalized Area
ST002741 AN004571 Integration of Meta-Multi-Omics Data Using Probabilistic Graphs and External Knowledge Cultured cells Lentilactobacillus kefiri University of Nebraska-Lincoln normalized intensity
ST002009 AN003275 Metabolomics analysis of stress erythroid progenitors Stem cells Mouse Inflammation Pennsylvania State University Normalized peak area
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002221 AN003630 Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002222 AN003631 Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC Cultured cells Human Cancer CECAD Research Center peak area
ST002371 AN003866 High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages Macrophages Mouse Inflammation Wake Forest School of Medicine peak area
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida Peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001279 AN002120 K13 mutations driving artemisinin resistance rewrite Plasmodium falciparum’s programmed intra-erythrocytic development and transform mitochondrial physiology Parasite Plasmodium falciparum Malaria Penn State Peak area
ST001384 AN002309 Plasmodium falciparum increased time in circulation underlies persistent asymptomatic infection in the dry season Blood Human Malaria Penn State Peak area
ST001441 AN002408 Metabolomics of patient-derived fibroblasts Fibroblast cells Human Mitochondrial disease North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University Peak area
ST001709 AN002784 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition Cultured cells Human COVID-19 University of California, Los Angeles Peak area
ST002237 AN003650 Metabolomic analysis of brain cortex from neuronal specific Depdc5 knockout in fed and fasting state Brain Mouse Northwestern University Feinberg School of Medicine Peak area
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China Peak area
ST002506 AN004128 Natural abundance of isotopic metabolite detection in mouse eye orgnaoids. Retina Mouse Northwestern University Peak area
ST002507 AN004129 Time-course analysis of C13 labeling in mouse eye organoids. Retina Mouse Northwestern University Peak area
ST002508 AN004130 13C-isotopic labeling of mouse eye organoids under three conditions. Retina Mouse Northwestern University Peak area
ST002846 AN004664 Apolipoprotein E suppresses hyperlipidemia-driven hematopoiesis & inflammation by controlling mitochondrial metabolism Macrophages Mouse Hyperlipidemia Northwestern University Peak area
ST002876 AN004713 High Level Expression of NSD2 Creates a Metabolic Dependency in Multiple Myeloma B-cells Human Cancer University of Florida Peak area
ST003249 AN005322 Mitochondrial respiration impairment in microglia dampens response to demyelinating injury but is not sufficient to induce an aging phenotype Microglia Mouse Alzheimers disease Northwestern University Peak area
ST003577 AN005873 Multi ‘omics indicate depth-discrete partitioning of nitrogen metabolism in a toxic Planktothrix rubescens bloom in the winter water column Water Other University of Tennessee Peak area
ST001954 AN003179 A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia Yeast cells Yeast Friedreichs Ataxia University of California, Los Angeles Peak Area
ST002709 AN004391 FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer Cultured cells Other Cancer University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Diabetes University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia University of California, Los Angeles Peak Area
ST002814 AN004706 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy Embryonic cells Mouse Hypoglycemia; Diabetes University of California, Los Angeles Peak Area
ST002852 AN004673 MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer Prostate Mouse Cancer University of California, Los Angeles Peak Area
ST002878 AN004716 Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. Embryonic cells Mouse Diabetes University of California, Los Angeles Peak Area
ST003111 AN005094 Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression, investigated with targeted metabolomics in Tam-Cre;Pkd1ΔC/flox mouse model kidneys. Kidney Mouse Kidney disease San Raffaele University Peak Area
ST003113 AN005100 Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression, investigated with targeted tracing metabolomics analysis in MEF cells using 15N2-glutamine. Cultured cells Mouse Kidney disease San Raffaele University Peak Area
ST002531 AN004165 Cellular consumption/release of polar metabolites by mPDAC cells cultured in different culture media conditions Media Mouse Cancer University of Chicago Peak area (m/z)
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST003340 AN005474 Effect of feeding and the mTORC1 activity on metabolism in Caenorhabditis elegans Worm Roundworm Hiroshima University peak areas
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center Peak area (top)
ST002926 AN004798 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University peak height
ST003036 AN004978 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences peak height
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University peak height
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000414 AN000655 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University Peak height
ST003160 AN005184 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University Peak height
ST002284 AN003733 Genetically defined human GBM organoids reveal principles of GBM development and actionable targets Cultured cells Human Cancer DKFZ peak intensity
ST000614 AN000939 Tobacco-specific carcinogens in Bladder Cancer Bladder Human Cancer Baylor College of Medicine Peak intensity
ST001191 AN001983 Metabonome of ginsenoside anti-tumor Tumor cells Human Cancer Nankai University Peak intensity
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001382 AN002303 Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis Bacterial cells E. coli CSIR National Chemical Laboratory Peak intensity
ST001547 AN002577 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University Peak intensity
ST001548 AN002579 β-Adrenergic regulation of metabolism in macrophages (part-II) Macrophages Human Monash University Peak intensity
ST001549 AN002580 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST001652 AN002699 Atypical Molecular Basis for Drug Resistance to Mitochondrial AQ: A Function Inhibitors in Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria U.S. Food & Drug Administration Peak intensity
ST003313 AN005425 Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - feces Feces Human Inflammatory bowel disease; Crohn disease Sheba hospital percentage of metabolites per sample
ST001299 AN002163 Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran Intestine Mouse The Pennsylvania State University (Penn State) ppm
ST001759 AN002866 Application of the redox metabolite detection method for mouse liver Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001760 AN002867 Application of the redox metabolite detection method for mouse kidney Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001761 AN002868 Application of the redox metabolite detection method for mouse biofluids Cerebrospinal fluid Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001762 AN002869 Application of the redox metabolite detection method for mouse kidney (part II) Kidney Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001763 AN002870 Application of the redox metabolite detection method for mouse liver (part II) Liver Mouse Boston Children's Hospital, Harvard Medical School ppm
ST001764 AN002871 Application of the redox metabolite detection method for profiling redox state following pharmacologic perturbation with methotrexate Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST001765 AN002872 Optimization of redox metabolite detection in mammalian cells (part I) Cultured cells Human Boston Children's Hospital, Harvard Medical School ppm
ST002716 AN004404 Ventricle-specific myocardial protein and metabolite characterisation in healthy humans, with differential regulation in end-stage cardiomyopathies (Part 1) Heart Human Cardiomyopathy University of Sydney Relative abundance
ST002717 AN004406 Ventricle-specific myocardial protein and metabolite characterisation in healthy humans, with differential regulation in end-stage cardiomyopathies (Part 2) Heart Human Cardiomyopathy University of Sydney Relative abundance
ST002309 AN003772 Targeting malaria parasites with novel derivatives of azithromycin Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002729 AN004423 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University relative peak area
ST001175 AN001951 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University Signal Intensity
ST001315 AN002190 Retargeting azithromycin-like compounds as antimalarials with dual modality Blood Plasmodium falciparum Malaria Monash University Signal Intensity
  logo